Xanthohumol inhibits growth and vascularization of developing endometriotic lesions | Zendy

Jeannette RudzitisAuth | Zendy; Christina Körbel | Zendy; Cláudia Scheuer | Zendy; Michael D. Menger | Zendy; Matthias W. Laschke | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Xanthohumol inhibits growth and vascularization of developing endometriotic lesions

Author(s) -

Jeannette RudzitisAuth,

Christina Körbel,

Cláudia Scheuer,

Michael D. Menger,

Matthias W. Laschke

Publication year - 2012

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/des095

Subject(s) - xanthohumol , medicine , antral follicle , peritoneal cavity , immunohistochemistry , pathology , uterus , endocrinology , urology , ovary , andrology , biology , surgery , ecology , key (lock)

Xanthohumol is a prenylated flavonoid isolated from hops, which is known to act as a pleiotropic cancer chemopreventive agent owing to its anti-proliferative, anti-inflammatory and anti-angiogenic properties. In the present study, we analyzed, for the first time, whether this dietary compound may also be used for the treatment of endometriosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research